Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
BrainControl logo — (Iper) Natural Human-Machine Interfaces

BrainControl

(Iper) Natural Human-Machine Interfaces

Founded 2010 Italy Italy 2-10 employees Seed AI, Biotechnology +3

General Information

Company Name BrainControl
Founded Year 2010
Location Italy Italy
Employees 2-10
Industries AI, Biotechnology, Health Care +2
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with BrainControl. To contact BrainControl, visit braincontrol.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BrainControl compare?

A PDF of BrainControl and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BrainControl soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BrainControl

BrainControl is a company based in Italy that focuses on providing solutions for individuals suffering from degenerative neuromuscular diseases, ischemic or traumatic injuries, and severe physical and communicative disabilities. The company's slogan "(Iper) Natural Human-Machine Interfaces" encapsulates its mission to develop natural and intuitive communication interfaces. BrainControl identified a gap in the market, where the needs of at least 5 million individuals are not met by existing assistive technologies. Additionally, the company targets the most severe cases, such as "locked-in" or "apparent coma" patients who are unable to move or communicate but can perceive the world around them. BrainControl's flagship product, BrainControl AAC, leverages artificial intelligence and bio-feedback to create alternative augmentative communication devices for human-machine interaction. It incorporates two main modes of interaction—BCI AAC based on Brain-Computer Interface (BCI) technology and Sensory AAC. The former acts as a 'mental joystick', enabling individuals to overcome their physical limitations and communicate effectively. One prominent achievement of BrainControl is securing funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 947336. This signifies recognition and support for the company's innovative approach in the fields of AI, Biotechnology, Health Care, Information Technology, and Machine Learning. Overall, BrainControl's dedication to enhancing the quality of life for individuals with severe disabilities and its innovative use of AI and bio-feedback technology position it as a promising player in the assistive technology market, with potential appeal to investors seeking impactful and cutting-edge opportunities in the healthcare and AI sectors.

No funding data available for BrainControl yet.

FAQ About BrainControl

(Iper) Natural Human-Machine Interfaces
BrainControl was founded in 2010.
BrainControl is headquartered in Italy.
BrainControl operates in AI, Biotechnology, Health Care, Information Technology and Machine Learning.
BrainControl has approximately 2-10 employees.

We're actively collecting intelligence on BrainControl.

Source: BounceWatch company record for BrainControl, https://bouncewatch.com/company/braincontrol, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes